2023-10-27 2024-10-31 2024-10-31 false 15242737 GKAD HOLDINGS LIMITED 2025-09-05 false iso4217:GBP xbrli:pure 15242737 2023-10-26 15242737 2024-10-31 15242737 2023-10-27 2024-10-31 15242737 2023-10-25 15242737 2023-10-26 15242737 2023-10-26 2023-10-26 15242737 bus:SmallEntities 2023-10-27 2024-10-31 15242737 bus:AuditExempt-NoAccountantsReport 2023-10-27 2024-10-31 15242737 bus:FullAccounts 2023-10-27 2024-10-31 15242737 bus:PrivateLimitedCompanyLtd 2023-10-27 2024-10-31 15242737 core:WithinOneYear 2024-10-31 15242737 core:AfterOneYear 2024-10-31 15242737 core:WithinOneYear 2023-10-26 15242737 core:AfterOneYear 2023-10-26 15242737 core:ShareCapital 2024-10-31 15242737 core:SharePremium 2024-10-31 15242737 core:RevaluationReserve 2024-10-31 15242737 core:OtherReservesSubtotal 2024-10-31 15242737 core:RetainedEarningsAccumulatedLosses 2024-10-31 15242737 core:ShareCapital 2023-10-26 15242737 core:SharePremium 2023-10-26 15242737 core:RevaluationReserve 2023-10-26 15242737 core:OtherReservesSubtotal 2023-10-26 15242737 core:RetainedEarningsAccumulatedLosses 2023-10-26 15242737 core:LandBuildings 2024-10-31 15242737 core:PlantMachinery 2024-10-31 15242737 core:Vehicles 2024-10-31 15242737 core:FurnitureFittings 2024-10-31 15242737 core:OfficeEquipment 2024-10-31 15242737 core:NetGoodwill 2024-10-31 15242737 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 15242737 core:ListedExchangeTraded 2024-10-31 15242737 core:UnlistedNon-exchangeTraded 2024-10-31 15242737 core:LandBuildings 2023-10-26 15242737 core:PlantMachinery 2023-10-26 15242737 core:Vehicles 2023-10-26 15242737 core:FurnitureFittings 2023-10-26 15242737 core:OfficeEquipment 2023-10-26 15242737 core:NetGoodwill 2023-10-26 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-26 15242737 core:ListedExchangeTraded 2023-10-26 15242737 core:UnlistedNon-exchangeTraded 2023-10-26 15242737 core:LandBuildings 2023-10-27 2024-10-31 15242737 core:PlantMachinery 2023-10-27 2024-10-31 15242737 core:Vehicles 2023-10-27 2024-10-31 15242737 core:FurnitureFittings 2023-10-27 2024-10-31 15242737 core:OfficeEquipment 2023-10-27 2024-10-31 15242737 core:NetGoodwill 2023-10-27 2024-10-31 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-27 2024-10-31 15242737 core:ListedExchangeTraded 2023-10-27 2024-10-31 15242737 core:UnlistedNon-exchangeTraded 2023-10-27 2024-10-31 15242737 core:MoreThanFiveYears 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments 2024-10-31 15242737 core:Non-currentFinancialInstruments 2023-10-26 15242737 dpl:CostSales 2023-10-27 2024-10-31 15242737 dpl:DistributionCosts 2023-10-27 2024-10-31 15242737 core:LandBuildings 2023-10-27 2024-10-31 15242737 core:PlantMachinery 2023-10-27 2024-10-31 15242737 core:Vehicles 2023-10-27 2024-10-31 15242737 core:FurnitureFittings 2023-10-27 2024-10-31 15242737 core:OfficeEquipment 2023-10-27 2024-10-31 15242737 dpl:AdministrativeExpenses 2023-10-27 2024-10-31 15242737 core:NetGoodwill 2023-10-27 2024-10-31 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-27 2024-10-31 15242737 dpl:GroupUndertakings 2023-10-27 2024-10-31 15242737 dpl:ParticipatingInterests 2023-10-27 2024-10-31 15242737 dpl:GroupUndertakings core:ListedExchangeTraded 2023-10-27 2024-10-31 15242737 core:ListedExchangeTraded 2023-10-27 2024-10-31 15242737 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-10-27 2024-10-31 15242737 core:UnlistedNon-exchangeTraded 2023-10-27 2024-10-31 15242737 dpl:CostSales 2023-10-26 2023-10-26 15242737 dpl:DistributionCosts 2023-10-26 2023-10-26 15242737 core:LandBuildings 2023-10-26 2023-10-26 15242737 core:PlantMachinery 2023-10-26 2023-10-26 15242737 core:Vehicles 2023-10-26 2023-10-26 15242737 core:FurnitureFittings 2023-10-26 2023-10-26 15242737 core:OfficeEquipment 2023-10-26 2023-10-26 15242737 dpl:AdministrativeExpenses 2023-10-26 2023-10-26 15242737 core:NetGoodwill 2023-10-26 2023-10-26 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-26 2023-10-26 15242737 dpl:GroupUndertakings 2023-10-26 2023-10-26 15242737 dpl:ParticipatingInterests 2023-10-26 2023-10-26 15242737 dpl:GroupUndertakings core:ListedExchangeTraded 2023-10-26 2023-10-26 15242737 core:ListedExchangeTraded 2023-10-26 2023-10-26 15242737 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-10-26 2023-10-26 15242737 core:UnlistedNon-exchangeTraded 2023-10-26 2023-10-26 15242737 core:NetGoodwill 2024-10-31 15242737 core:IntangibleAssetsOtherThanGoodwill 2024-10-31 15242737 core:LandBuildings 2024-10-31 15242737 core:PlantMachinery 2024-10-31 15242737 core:Vehicles 2024-10-31 15242737 core:FurnitureFittings 2024-10-31 15242737 core:OfficeEquipment 2024-10-31 15242737 core:AfterOneYear 2024-10-31 15242737 core:WithinOneYear 2024-10-31 15242737 core:ListedExchangeTraded 2024-10-31 15242737 core:UnlistedNon-exchangeTraded 2024-10-31 15242737 core:ShareCapital 2024-10-31 15242737 core:SharePremium 2024-10-31 15242737 core:RevaluationReserve 2024-10-31 15242737 core:OtherReservesSubtotal 2024-10-31 15242737 core:RetainedEarningsAccumulatedLosses 2024-10-31 15242737 core:NetGoodwill 2023-10-26 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-26 15242737 core:LandBuildings 2023-10-26 15242737 core:PlantMachinery 2023-10-26 15242737 core:Vehicles 2023-10-26 15242737 core:FurnitureFittings 2023-10-26 15242737 core:OfficeEquipment 2023-10-26 15242737 core:AfterOneYear 2023-10-26 15242737 core:WithinOneYear 2023-10-26 15242737 core:ListedExchangeTraded 2023-10-26 15242737 core:UnlistedNon-exchangeTraded 2023-10-26 15242737 core:ShareCapital 2023-10-26 15242737 core:SharePremium 2023-10-26 15242737 core:RevaluationReserve 2023-10-26 15242737 core:OtherReservesSubtotal 2023-10-26 15242737 core:RetainedEarningsAccumulatedLosses 2023-10-26 15242737 core:NetGoodwill 2023-10-25 15242737 core:IntangibleAssetsOtherThanGoodwill 2023-10-25 15242737 core:LandBuildings 2023-10-25 15242737 core:PlantMachinery 2023-10-25 15242737 core:Vehicles 2023-10-25 15242737 core:FurnitureFittings 2023-10-25 15242737 core:OfficeEquipment 2023-10-25 15242737 core:AfterOneYear 2023-10-25 15242737 core:WithinOneYear 2023-10-25 15242737 core:ListedExchangeTraded 2023-10-25 15242737 core:UnlistedNon-exchangeTraded 2023-10-25 15242737 core:ShareCapital 2023-10-25 15242737 core:SharePremium 2023-10-25 15242737 core:RevaluationReserve 2023-10-25 15242737 core:OtherReservesSubtotal 2023-10-25 15242737 core:RetainedEarningsAccumulatedLosses 2023-10-25 15242737 core:AfterOneYear 2023-10-27 2024-10-31 15242737 core:WithinOneYear 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:CostValuation 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-10-27 2024-10-31 15242737 core:Non-currentFinancialInstruments core:CostValuation 2024-10-31 15242737 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-10-31 15242737 core:Non-currentFinancialInstruments core:CostValuation 2023-10-26 15242737 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-10-26 15242737 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-10-26 15242737 bus:Director1 2023-10-27 2024-10-31 15242737 bus:Director2 2023-10-27 2024-10-31

GKAD HOLDINGS LIMITED

Registered Number
15242737
(England and Wales)

Unaudited Financial Statements for the Period ended
31 October 2024

GKAD HOLDINGS LIMITED
Company Information
for the period from 27 October 2023 to 31 October 2024

Directors | AHLUWALIA, Avneet
| DANG, Balvinder Singh

Registered Address | Culverwood Shinfield Road
| Shinfield
| Reading
| RG2 9BE

Registered Number | 15242737 (England and Wales)

GKAD HOLDINGS LIMITED
Balance Sheet as at
31 October 2024

| Notes | 2024
--- | --- | ---
|  | £ |  | £
Fixed assets |  |  |  |
Investments | 3 |  |  | 754,996
|  |  |  | 754,996
Current assets |  |  |  |
Debtors | 4 | 7,141 |  |
Cash at bank and on hand |  | 1,137,126 |  |
|  | 1,144,267 |  |
Creditors amounts falling due within one year | 5 | (554,293) |  |
Net current assets (liabilities) |  |  |  | 589,974
Total assets less current liabilities |  |  |  | 1,344,970
Net assets |  |  |  | 1,344,970
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 101
Profit and loss account |  |  |  | 1,344,869
Shareholders' funds |  |  |  | 1,344,970

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 5 September 2025, and are signed on its behalf by:
DANG, Balvinder Singh Director Registered Company No. 15242737

GKAD HOLDINGS LIMITED
Notes to the Financial Statements
for the period ended 31 October 2024

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Interest income
--- | ---
| Interest income is recognised using the effective interest rate method.

| Dividend income
--- | ---
| Dividend income is recognised when the right to receive payment is established.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

| Trade and other debtors
--- | ---
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

| Trade and other creditors
--- | ---
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

| Financial instruments
--- | ---
| A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

| Share capital
--- | ---
| Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2. | Average number of employees
--- | ---

|  | 2024
| Average number of employees during the year | 0

3. | Fixed asset investments
--- | ---

|  | Investments in groups1 |  | Other loans2 |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| Additions | 202,914 |  | 552,082 |  | 754,996
| At 31 October 24 | 202,914 |  | 552,082 |  | 754,996
| Net book value
| At 31 October 24 | 202,914 |  | 552,082 |  | 754,996

| Notes
--- | ---
| 1Investments in group undertakings and participating interests 2Other loans classified under investments

4. | Debtors: amounts due within one year
--- | ---

|  | 2024
--- | --- | ---
|  | £
| Trade debtors / trade receivables | 1
| Prepayments and accrued income | 7,140
| Total | 7,141

5. | Creditors: amounts due within one year
--- | ---

|  | 2024
--- | --- | ---
|  | £
| Amounts owed to related parties | 552,082
| Taxation and social security | 1,611
| Accrued liabilities and deferred income | 600
| Total | 554,293